It is a home appliances private limited company based in Narela, Delhi, India, established in 2023.
2023 | Narela, Delhi, India | ActiveRx Plus Pharmaceuticals Private Limited, a active private limited company, was established on 10 January 2023 in Narela, Delhi, India. Engaging in household goods within the home appliances sector, it holds CIN: U51397DL2023PTC409712. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sudha Jain (Director), Abhinav Jain (Director), Parveen (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 1, 3Rs Floor, Chetan Plaza Building No. 301&351, Pkt-2 Sec A-9, Narela, Delhi, 110040.
U51397DL2023PTC409712
409712
10 January 2023
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rx Plus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sudha Jain | Director | 10 Jan 2023 | Current |
| Abhinav Jain | Director | 10 Jan 2023 | Current |
| Parveen | Director | 10 Jan 2023 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Rx Plus Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Rx Plus Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Rx Plus Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Rx Plus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rx Plus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rx Plus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Rx Plus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Sudha Jain was appointed as a Director was appointed as a Director on 10 Jan 2023 & has been associated with this company since 2 years 11 months . was documented.
The activity Abhinav Jain was appointed as a Director was appointed as a Director on 10 Jan 2023 & has been associated with this company since 2 years 11 months . was completed.
Parveen was appointed as a Director was appointed as a Director on 10 Jan 2023 & has been associated with this company since 2 years 11 months . was recorded as a recent event.
Progress on Rx Plus Pharmaceuticals Private Limited was registered on 10 Jan 2023 with Roc Delhi & aged 2 years 11 months as per MCA records. was documented.
The CIN of Rx Plus Pharmaceuticals Private Limited is U51397DL2023PTC409712.
Rx Plus Pharmaceuticals Private Limited is headquartered at Plot No. 1, 3Rs Floor, Chetan Plaza Building No. 301&351, Pkt-2 Sec A-9, Narela, Delhi, 110040.
Rx Plus Pharmaceuticals Private Limited was incorporated on 10 January 2023.
The current directors of Rx Plus Pharmaceuticals Private Limited are
The primary industry of Rx Plus Pharmaceuticals Private Limited is Home Appliances.
Rx Plus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Rx Plus Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Rx Plus Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX